Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Fuji
McKesson
McKinsey
Deloitte
Johnson and Johnson
Teva
Accenture
AstraZeneca

Generated: August 17, 2018

DrugPatentWatch Database Preview

COLAZAL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Colazal, and what generic alternatives are available?

Colazal is a drug marketed by Valeant Pharms Intl and is included in one NDA. There are two patents protecting this drug.

This drug has thirty-four patent family members in eleven countries.

The generic ingredient in COLAZAL is balsalazide disodium. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.

Drug patent expirations by year for COLAZAL
Synonyms for COLAZAL
(3E)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid
(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid
(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazono]-6-oxo-cyclohexa-1,4-diene-1-carboxylic acid
(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid
(E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoicacid
(E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid
(E)-5-[[4-[[(2-Carboxyethyl)amino]-carbonyl]phenyl]azo-2-hydroxybenzoic acid
(E)-5-[[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]azo]-2-hydroxybenzoic Acid
(Z)-3-(2-(4-((2-carboxyethyl)carbamoyl)phenyl)hydrazono)-6-oxocyclohexa-1,4-diene-1-carboxylic acid
3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid
399030-81-0
5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-benzoicaci(e
5-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}diazen-1-yl)-2-hydroxybenzoic acid
5-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxybenzoic Acid
5-[(E)-{4-[(2-carboxyethyl)carbamoyl]phenyl}diazenyl]-2-hydroxybenzoic acid
5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid
5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid
573B042
80573-04-2
AB0020029
AB01209737-01
AC-8500
AC1NSFNR
AC1O3RJF
AK-51728
AKOS015892568
Ambap80573-04-2
AN-7937
AS-17568
Bacitracin zinc, Antibiotic for Culture Media Use Only
Balsalazida
Balsalazida [Spanish]
BALSALAZIDE
Balsalazide (INN)
Balsalazide [INN:BAN]
Balsalazide Disodium
Balsalazide sodium
Balsalazido
Balsalazido [Spanish]
Balsalazidum
Balsalazidum [Latin]
benzoic acid, 5-((1e)-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-
Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, (E)-
BIDD:GT0772
C17H15N3O6
CAS-80573-04-2
CCG-101140
CHEBI:267413
CHEBI:94605
CHEMBL1201346
CHEMBL1208641
Colazal (TN)
Colazide
Colazide (TN)
CPD000469221
CS-2899
D07488
D0A6KR
DB01014
DR001860
DSSTox_CID_20653
DSSTox_GSID_40653
DSSTox_RID_79523
DTXSID7040653
HMS2052K19
HMS2233C19
HY-B0667
I04-0033
KB-209256
KS-5215
LS-36369
MLS001424257
MolPort-005-934-178
NC00390
NCGC00164634-01
NCGC00164634-02
NE31766
OR343587
P80AL8J7ZP
Q-200671
SAM001246804
SCHEMBL118300
SCHEMBL138311
SCHEMBL142548
SCHEMBL15841310
SMR000469221
TC-149982
Tox21_112252
Tox21_112252_1
UNII-P80AL8J7ZP
V0740
ZINC100056740
ZINC13863965

US Patents and Regulatory Information for COLAZAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms Intl COLAZAL balsalazide disodium CAPSULE;ORAL 020610-001 Jul 18, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms Intl COLAZAL balsalazide disodium CAPSULE;ORAL 020610-001 Jul 18, 2000 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for COLAZAL

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,921,344 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives ➤ Try a Free Trial
9,192,616 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Covington
Teva
US Army
QuintilesIMS
Healthtrust
Medtronic
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.